Min Su
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 13
- RNA Research and Splicing 8
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 5
-
- Cancer-related molecular mechanisms research 20
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 7
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Qianjin Liao (27 shared papers)Yujuan Zhou (17 shared papers)Longzheng Xia (16 shared papers)Linda Oyang (16 shared papers)Yanyan Tang (14 shared papers)Shiming Tan (15 shared papers)Wenxiang Wang (14 shared papers)Yuhang Xiao (11 shared papers)
- Journals
- Oncotarget (4 papers)Scientific Reports (3 papers)Journal of Cancer (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Min Su
57 papers receiving 3.2k citations
Min Su's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 1.3k
- Molecular Biology 1.9k
- Oncology 530
- Immunology 420
- Pulmonary and Respiratory Medicine 253
Countries citing papers authored by Min Su
This map shows the geographic impact of Min Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Su more than expected).
Fields of papers citing papers by Min Su
This network shows the impact of papers produced by Min Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Su. The network helps show where Min Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cancer metabolic reprogramming and immune response Hit paper breakdown → | 2021 | 888 |
| 2 | 2019 | 329 | |
| 3 | 2017 | 194 | |
| 4 | 2019 | 174 | |
| 5 | 2020 | 156 | |
| 6 | 2020 | 150 | |
| 7 | 2019 | 131 | |
| 8 | 2022 | 75 | |
| 9 | 2016 | 70 | |
| 10 | 2020 | 65 | |
| 11 | 2018 | 55 | |
| 12 | 2018 | 54 | |
| 13 | 2018 | 53 | |
| 14 | 2021 | 48 | |
| 15 | 2018 | 47 | |
| 16 | 2019 | 43 | |
| 17 | 2017 | 40 | |
| 18 | 2022 | 39 | |
| 19 | 2020 | 37 | |
| 20 | 2020 | 37 |
About Min Su
Min Su is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (13 papers), RNA Research and Splicing (8 papers), MicroRNA in disease regulation (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Circular RNAs in diseases (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.9k citations), Oncology (530 citations), Immunology (420 citations) and Pulmonary and Respiratory Medicine (253 citations). Min Su has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Qianjin Liao, Yujuan Zhou, Longzheng Xia, Linda Oyang, Yanyan Tang, Shiming Tan, Wenxiang Wang, Yuhang Xiao, Deliang Cao and Jinguan Lin. Their work appears in journals such as Oncotarget, Scientific Reports, Journal of Cancer, Journal of Experimental & Clinical Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.